Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
|
Special Voting Preferred Stock |
Common |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Total Stockholder's Equity |
Noncontrolling Interest in Consolidated Subsidiary |
Total |
Balance at Jun. 30, 2019 |
|
$ 1,059
|
$ 46,299,233
|
|
$ (27,582,558)
|
$ 18,717,734
|
|
$ 18,717,734
|
Balance (in Shares) at Jun. 30, 2019 |
|
10,589,746
|
|
|
|
|
|
|
Common stock issued upon warrant exercise |
|
$ 37
|
4,247,028
|
|
|
4,247,065
|
|
4,247,065
|
Common stock issued upon warrant exercise (in Shares) |
|
369,311
|
|
|
|
|
|
|
Common stock issued in business combinations |
|
$ 230
|
20,081,236
|
|
|
20,081,466
|
|
20,081,466
|
Common stock issued in business combinations (in Shares) |
|
2,299,650
|
|
|
|
|
|
|
Non-controlling interest in acquired subsidiary |
|
|
|
|
|
|
5,554,011
|
5,554,011
|
Stock-based compensation |
|
|
1,253,234
|
|
|
1,253,234
|
|
1,253,234
|
Forfeitures of restricted shares |
|
$ (5)
|
5
|
|
|
|
|
|
Forfeitures of restricted shares (in Shares) |
|
(54,901)
|
|
|
|
|
|
|
Change in fair value of Convertible Notes |
|
|
|
63,000
|
|
63,000
|
|
63,000
|
Warrant Adjustment |
|
|
21,738
|
|
|
21,738
|
|
21,738
|
Foreign currency translation adjustments |
|
|
|
|
|
|
|
|
Unrealized (loss) gains on convertible notes |
|
|
|
|
|
|
|
63,000
|
Net loss |
|
|
|
|
(13,572,311)
|
(13,572,311)
|
(849,759)
|
(14,422,070)
|
Balance at Jun. 30, 2020 |
|
$ 1,321
|
71,902,474
|
63,000
|
(41,154,869)
|
30,811,926
|
4,704,252
|
35,516,178
|
Balance (in Shares) at Jun. 30, 2020 |
|
13,203,806
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
|
|
|
|
(21,497)
|
Unrealized (loss) gains on convertible notes |
|
|
|
|
|
|
|
(133,000)
|
Net loss |
|
|
|
|
|
|
|
(16,219,296)
|
Balance at Dec. 31, 2020 |
$ 20,405,219
|
$ 1,990
|
94,086,433
|
(91,497)
|
(57,179,525)
|
57,222,620
|
|
57,222,620
|
Balance (in Shares) at Dec. 31, 2020 |
2,667,349
|
19,901,248
|
|
|
|
|
|
|
Adoption of ASC 606 Adjustment |
|
|
|
|
185,825
|
185,825
|
|
185,825
|
Balance at Jul. 01, 2020 |
|
$ 1,321
|
71,902,474
|
63,000
|
(40,969,044)
|
30,997,751
|
4,704,252
|
35,702,003
|
Balance (in Shares) at Jul. 01, 2020 |
|
13,203,806
|
|
|
|
|
|
|
Issuance of common stock |
|
$ 500
|
11,031,880
|
|
|
11,032,380
|
|
11,032,380
|
Issuance of common stock (in Shares) |
|
5,000,000
|
|
|
|
|
|
|
Special voting preferred stock issued in business combination |
$ 25,203,490
|
|
|
|
|
25,203,490
|
|
25,203,490
|
Special voting preferred stock issued in business combination (in Shares) |
3,294,574
|
|
|
|
|
|
|
|
Conversion of Exchangeable Shares to common stock |
$ (4,798,271)
|
$ 63
|
4,798,208
|
|
|
|
|
|
Conversion of Exchangeable Shares to common stock (in Shares) |
(627,225)
|
627,225
|
|
|
|
|
|
|
Settlement of convertible debt |
|
$ 11
|
359,989
|
|
|
360,000
|
|
360,000
|
Settlement of convertible debt (in Shares) |
|
112,867
|
|
|
|
|
|
|
Non-controlling interest in acquired subsidiary |
|
$ 80
|
4,695,357
|
|
|
4,695,437
|
(4,695,437)
|
|
Non-controlling interest in acquired subsidiary (in Shares) |
|
800,000
|
|
|
|
|
|
|
Stock-based compensation |
|
|
1,298,540
|
|
|
1,298,540
|
|
1,298,540
|
Restricted stock vesting |
|
$ 15
|
(15)
|
|
|
|
|
|
Restricted stock vesting (in Shares) |
|
157,350
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
(21,497)
|
|
(21,497)
|
|
(21,497)
|
Unrealized (loss) gains on convertible notes |
|
|
|
(133,000)
|
|
(133,000)
|
|
(133,000)
|
Net loss |
|
|
|
|
(16,210,481)
|
(16,210,481)
|
(8,815)
|
(16,219,296)
|
Balance at Dec. 31, 2020 |
$ 20,405,219
|
$ 1,990
|
94,086,433
|
(91,497)
|
(57,179,525)
|
57,222,620
|
|
57,222,620
|
Balance (in Shares) at Dec. 31, 2020 |
2,667,349
|
19,901,248
|
|
|
|
|
|
|
Conversion of Exchangeable Shares to common stock |
$ (7,803,475)
|
$ 102
|
7,803,373
|
|
|
|
|
|
Conversion of Exchangeable Shares to common stock (in Shares) |
(1,020,062)
|
1,020,062
|
|
|
|
|
|
|
Settlement of convertible debt |
|
$ 208
|
8,467,292
|
|
|
|
|
8,467,500
|
Settlement of convertible debt (in Shares) |
|
2,080,140
|
|
|
|
|
|
|
Shares withheld for withholding taxes |
|
$ (5)
|
(333,842)
|
|
|
|
|
(333,847)
|
Shares withheld for withholding taxes (in Shares) |
|
(48,948)
|
|
|
|
|
|
|
Stock-based compensation |
|
|
503,379
|
|
|
|
|
503,379
|
Restricted stock vesting |
|
$ 1
|
(1)
|
|
|
|
|
|
Restricted stock vesting (in Shares) |
|
13,978
|
|
|
|
|
|
|
Forfeitures of restricted shares |
|
|
|
|
|
|
|
|
Forfeitures of restricted shares (in Shares) |
|
(668)
|
|
|
|
|
|
|
Liabilities settled with shares |
|
$ 10
|
377,315
|
|
|
|
|
377,325
|
Liabilities settled with shares (in Shares) |
|
101,705
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
(230)
|
|
|
|
(230)
|
Unrealized (loss) gains on convertible notes |
|
|
|
(13,000)
|
|
|
|
(13,000)
|
Net loss |
|
|
|
|
(6,457,703)
|
|
|
(6,457,703)
|
Balance at Mar. 31, 2021 |
$ 12,601,744
|
$ 2,306
|
110,903,949
|
(104,727)
|
(63,637,228)
|
|
|
59,766,044
|
Balance (in Shares) at Mar. 31, 2021 |
1,647,287
|
23,067,517
|
|
|
|
|
|
|
Balance at Dec. 31, 2020 |
$ 20,405,219
|
$ 1,990
|
94,086,433
|
(91,497)
|
(57,179,525)
|
57,222,620
|
|
$ 57,222,620
|
Balance (in Shares) at Dec. 31, 2020 |
2,667,349
|
19,901,248
|
|
|
|
|
|
|
Issuance of common stock (in Shares) |
|
|
|
|
|
|
|
556,388
|
Conversion of Exchangeable Shares to common stock |
$ (18,039,181)
|
$ 237
|
18,038,944
|
|
|
|
|
|
Conversion of Exchangeable Shares to common stock (in Shares) |
(2,358,063)
|
2,358,063
|
|
|
|
|
|
|
Settlement of convertible debt |
|
$ 309
|
11,610,277
|
|
|
11,610,586
|
|
$ 11,610,586
|
Settlement of convertible debt (in Shares) |
|
3,094,129
|
|
|
|
|
|
12,484,395
|
Shares withheld for withholding taxes |
|
$ (12)
|
(520,383)
|
|
|
(520,395)
|
|
$ (520,395)
|
Shares withheld for withholding taxes (in Shares) |
|
(121,786)
|
|
|
|
|
|
|
Shares issued in connection with Viridian Acquisition |
|
$ 103
|
6,187,897
|
|
|
6,188,000
|
|
6,188,000
|
Shares issued in connection with Viridian Acquisition (in Shares) |
|
1,031,000
|
|
|
|
|
|
|
Shares issued in connection with Asset Purchase |
|
$ 8
|
299,992
|
|
|
300,000
|
|
300,000
|
Shares issued in connection with Asset Purchase (in Shares) |
|
83,333
|
|
|
|
|
|
|
Shares issued in connection with 365 Cannabis Acquisition |
|
$ 357
|
11,995,704
|
|
|
11,996,061
|
|
11,996,061
|
Shares issued in connection with 365 Cannabis Acquisition (in Shares) |
|
3,571,429
|
|
|
|
|
|
|
Stock-based compensation |
|
|
2,070,358
|
|
|
2,070,358
|
|
2,070,358
|
Shares issued in connection with the ATM program |
|
$ 56
|
1,828,063
|
|
|
1,828,119
|
|
1,828,119
|
Shares issued in connection with the ATM program (in Shares) |
|
556,388
|
|
|
|
|
|
|
Restricted stock vesting |
|
$ 42
|
(42)
|
|
|
|
|
|
Restricted stock vesting (in Shares) |
|
427,711
|
|
|
|
|
|
32,394
|
Forfeitures of restricted shares |
|
|
|
|
|
|
|
|
Forfeitures of restricted shares (in Shares) |
|
(1,336)
|
|
|
|
|
|
|
Liabilities settled with shares |
|
$ 10
|
430,015
|
|
|
430,025
|
|
430,025
|
Liabilities settled with shares (in Shares) |
|
101,705
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
53,020
|
|
53,020
|
|
53,020
|
Unrealized (loss) gains on convertible notes |
|
|
|
100,000
|
|
100,000
|
|
100,000
|
Net loss |
|
|
|
|
(31,328,711)
|
(31,328,711)
|
|
(31,328,711)
|
Balance at Dec. 31, 2021 |
$ 2,366,038
|
$ 3,100
|
146,027,258
|
61,523
|
(88,508,236)
|
$ 59,949,683
|
|
59,949,683
|
Balance (in Shares) at Dec. 31, 2021 |
309,286
|
31,001,884
|
|
|
|
|
|
|
Conversion of Exchangeable Shares to common stock |
$ (18,620)
|
|
18,620
|
|
|
|
|
|
Conversion of Exchangeable Shares to common stock (in Shares) |
(2,434)
|
2,434
|
|
|
|
|
|
|
Settlement of convertible debt |
|
$ 340
|
3,299,660
|
|
|
|
|
3,300,000
|
Settlement of convertible debt (in Shares) |
|
3,396,842
|
|
|
|
|
|
|
Shares withheld for withholding taxes |
|
|
(5,615)
|
|
|
|
|
(5,615)
|
Shares withheld for withholding taxes (in Shares) |
|
(4,421)
|
|
|
|
|
|
|
Shares returned in connection with 365 Cannabis acquisition |
|
$ (28)
|
(939,972)
|
|
|
|
|
(940,000)
|
Shares returned in connection with 365 Cannabis acquisition (in Shares) |
|
(279,762)
|
|
|
|
|
|
|
Stock-based compensation |
|
|
316,855
|
|
|
|
|
316,855
|
Restricted stock vesting |
|
$ 4
|
(4)
|
|
|
|
|
|
Restricted stock vesting (in Shares) |
|
43,479
|
|
|
|
|
|
|
Liabilities settled with shares |
|
$ 1
|
45,065
|
|
|
|
|
45,066
|
Liabilities settled with shares (in Shares) |
|
14,632
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
|
(33,800)
|
|
|
|
(33,800)
|
Unrealized (loss) gains on convertible notes |
|
|
|
101,000
|
|
|
|
101,000
|
Net loss |
|
|
|
|
(21,952,893)
|
|
|
(21,952,893)
|
Balance at Mar. 31, 2022 |
$ 2,347,418
|
$ 3,417
|
$ 148,761,867
|
$ 128,723
|
$ (110,461,129)
|
|
|
$ 40,780,296
|
Balance (in Shares) at Mar. 31, 2022 |
306,852
|
34,175,088
|
|
|
|
|
|
|